- Home
- YSXT vs RNXT Comparison
YSXT vs RNXT Comparison
Compare YSXT & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSXT | RNXT |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | China | United States |
| Employees | 39 | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 37.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | YSXT | RNXT |
|---|---|---|
| Price | $0.95 | $0.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.25 |
| AVG Volume (30 Days) | 123.4K | ★ 289.1K |
| Earning Date | 02-03-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,123,000.00 |
| Revenue This Year | N/A | $194.66 |
| Revenue Next Year | N/A | $279.78 |
| P/E Ratio | $5.57 | ★ N/A |
| Revenue Growth | N/A | ★ 2511.63 |
| 52 Week Low | $0.97 | $0.70 |
| 52 Week High | $9.90 | $1.45 |
Technical Indicators
Market Signals| Indicator | YSXT | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 31.61 | 43.15 |
| Support Level | N/A | $0.89 |
| Resistance Level | $1.31 | $1.07 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 20.86 | 35.23 |
Price Performance
Historical ComparisonAbout YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.